Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. It also provides body contouring products; facial and nasal implants; saline-filled breast implant sizers to identify the correct style and size of implants; and non-breast tissue expanders for expanding tissue and skin surface area for burn care and other reconstructive use. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Phone805-562-3500
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$36.54 million
Profitability
Miscellaneous
Employees200
OptionableOptionable
Sientra (NASDAQ:SIEN) Frequently Asked Questions
What is Sientra's stock symbol?
Sientra trades on the NASDAQ under the ticker symbol "SIEN."
How were Sientra's earnings last quarter?
Sientra Inc (NASDAQ:SIEN) announced its quarterly earnings data on Tuesday, August, 7th. The medical instruments supplier reported ($0.73) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.69) by $0.04. The medical instruments supplier earned $17.55 million during the quarter, compared to analysts' expectations of $15.30 million. Sientra had a negative net margin of 126.03% and a negative return on equity of 132.84%. View Sientra's Earnings History.
When is Sientra's next earnings date?
What price target have analysts set for SIEN?
9 analysts have issued 12-month target prices for Sientra's shares. Their forecasts range from $16.00 to $31.00. On average, they anticipate Sientra's share price to reach $24.2857 in the next year. This suggests a possible upside of 133.3% from the stock's current price. View Analyst Price Targets for Sientra.
What is the consensus analysts' recommendation for Sientra?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last year. There are currently 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sientra.
Has Sientra been receiving favorable news coverage?
News articles about SIEN stock have been trending somewhat positive on Sunday, InfoTrie reports. The research firm scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Sientra earned a coverage optimism score of 1.4 on InfoTrie's scale. They also assigned media stories about the medical instruments supplier a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term.
Who are some of Sientra's key competitors?
Some companies that are related to Sientra include Establishment Labs (ESTA), RTI Surgical (RTIX), Invacare (IVC), Lakeland Industries (LAKE), ConforMIS (CFMS), COLLPLANT HOLDI/S (CLGN), NanoVibronix (NAOV), Wound Management Technologies (WNDM), Precision Therapeutics (AIPT), Bionik Laboratories (BNKL), Rewalk Robotics (RWLK), Histogenics (HSGX), Allied Healthcare Products (AHPI), Avitar (AVTI) and Halyard Health (HYH).
Who are Sientra's key executives?
Sientra's management team includes the folowing people:
- Mr. Jeffrey M. Nugent, Chairman & CEO (Age 72)
- Mr. Charles Huiner, COO and Sr. VP of Corp. Devel. & Strategy (Age 48)
- Mr. Patrick F. Williams, Sr. VP & GM of miraDry (Age 46)
- Mr. Keith J. Sullivan, Director & Advisor (Age 61)
- Mr. Paul Sean Little, CFO, Sr. VP & Treasurer (Age 54)
Who are Sientra's major shareholders?
Sientra's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (5.65%), Millennium Management LLC (3.38%), Polar Capital LLP (3.16%), Lord Abbett & CO. LLC (1.64%), Geode Capital Management LLC (0.89%) and United Services Automobile Association (0.88%). Company insiders that own Sientra stock include Jeffrey M Nugent, Patrick F Williams, R Scott Greer and Timothy Haines. View Institutional Ownership Trends for Sientra.
Which institutional investors are selling Sientra stock?
SIEN stock was sold by a variety of institutional investors in the last quarter, including Columbus Circle Investors, Lord Abbett & CO. LLC, Polar Capital LLP, Bank of New York Mellon Corp, Creative Planning, Quantum Capital Management, Birchview Capital LP and First Mercantile Trust Co.. Company insiders that have sold Sientra company stock in the last year include Jeffrey M Nugent and Timothy Haines. View Insider Buying and Selling for Sientra.
Which institutional investors are buying Sientra stock?
SIEN stock was purchased by a variety of institutional investors in the last quarter, including Millennium Management LLC, Two Sigma Investments LP, BlackRock Inc., Cannell Capital LLC, Squarepoint Ops LLC, Stephens Inc. AR, Geode Capital Management LLC and Bank of America Corp DE. Company insiders that have bought Sientra stock in the last two years include Jeffrey M Nugent, Patrick F Williams, R Scott Greer and Timothy Haines. View Insider Buying and Selling for Sientra.
How do I buy shares of Sientra?
Shares of SIEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Sientra's stock price today?
One share of SIEN stock can currently be purchased for approximately $10.41.
How big of a company is Sientra?
Sientra has a market capitalization of $297.72 million and generates $36.54 million in revenue each year. The medical instruments supplier earns $-64,020,000.00 in net income (profit) each year or ($2.82) on an earnings per share basis. Sientra employs 200 workers across the globe.
What is Sientra's official website?
How can I contact Sientra?
Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier can be reached via phone at 805-562-3500 or via email at [email protected]
MarketBeat Community Rating for Sientra (NASDAQ SIEN)
MarketBeat's community ratings are surveys of what our community members think about Sientra and other stocks. Vote "Outperform" if you believe SIEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SIEN will underperform the S&P 500 over the long term. You may vote once every thirty days.
